ROLE OF JYOTISHMATYADIVATI AND CHATURBEEJAVATI IN IRREGULAR AND SCANTY MENSES

AN OPEN LABELED RANDOMIZED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF JYOTISHMATYADI VATI AND CHATURBEEJA VATI IN ARTAVAKSHAYA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031204

Enrollment

Registered

2021-02-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified Health Condition 2: N915- Oligomenorrhea, unspecified

Interventions

Intervention1: JYOTISHMATYADI VATI : Jyotishmatyadi Vati- 2 tab of 500mg twice a day with lukewarm water before food, for 2 consecutive cycle.Followup on every 15 days for 2 consecutive cycle.final fo

Eligibility

Inclusion criteria

Inclusion criteria: 1 Unmarried or married women between 15-35 years. 2 Subjects presenting with the Pratyatmalakshana of ArtavaKshaya- (i)Yathochitakala-adarshanam (Oligomenorrhoea-infrequent menses at an interval longer than 35 days & irregular menses. (ii)Alpata(Hypomenorrhoea)scanty menses. (iii)Yonivedana (Dysmenorrhoea)painful menses with above symptoms. 3 Secondary Amenorrhoea (upto 6 months) 4 Mild Anemic (Hb- 11 to 11.9 g/dl) & Moderate Anemic Women (Hb- 8 to 10.9 g/dl)

Exclusion criteria

Exclusion criteria: 1 Lactating women 2 Peri Menopause & Post Menopause women 3 Pregnant women 4 Patients on oral contraceptive pills 5 Patients having Intra Uterine Contraceptive Device. 6 Severe Anemic Women (Hb 7 Patients with known cases of any systemic disorders like Diabetes mellitus, Tuberculosis,Hypertension,Asthma,congenital abnormalities of reproductive system,Endocrine disorders like Thyroid dysfunction,PCOS,Menometrorrhagia,Chronic Psychosomatic Disorders.

Design outcomes

Primary

Measure	Time frame
To maintain normal menstrual interval and to bring adequate menstrual bleedingTimepoint: 90 days	—

Secondary

Measure	Time frame
To maintain normal menstruation and manage associated symptoms like dysmenorrhoea and secondary amenorrhoeaTimepoint: 90 days	—

Countries

India

Contacts

Public ContactDR ASOKAN V

PARUL INSTITUTE OF AYURVED

drasokan24@gmail.com6361740431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026